DWTX — Dogwood Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Dogwood Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	14	7.03	3.32	14.8	6.52
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15.8	8.37	4.17	16.5	8.43
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	0.223	0.176
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	15.8	8.37	4.17	94.3	90.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.28	1.04	0.359	3.18	3.06
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.28	1.04	0.359	30	15.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	14.5	7.33	3.81	64.3	74.9
Total Liabilities & Shareholders' Equity	15.8	8.37	4.17	94.3	90.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding